Medical Cannabis Payment Solutions (OTCMKTS:REFG – Get Free Report) and Payoneer Global (NASDAQ:PAYO – Get Free Report) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.
Volatility & Risk
Medical Cannabis Payment Solutions has a beta of -0.13, suggesting that its share price is 113% less volatile than the S&P 500. Comparatively, Payoneer Global has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500.
Insider and Institutional Ownership
82.2% of Payoneer Global shares are owned by institutional investors. 5.6% of Payoneer Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Medical Cannabis Payment Solutions | N/A | N/A | N/A |
Payoneer Global | 13.82% | 17.78% | 1.73% |
Earnings & Valuation
This table compares Medical Cannabis Payment Solutions and Payoneer Global”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Medical Cannabis Payment Solutions | $140,000.00 | N/A | -$30,000.00 | N/A | N/A |
Payoneer Global | $940.30 million | 3.96 | $93.33 million | $0.35 | 29.86 |
Payoneer Global has higher revenue and earnings than Medical Cannabis Payment Solutions.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Medical Cannabis Payment Solutions and Payoneer Global, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Medical Cannabis Payment Solutions | 0 | 0 | 0 | 0 | 0.00 |
Payoneer Global | 0 | 1 | 5 | 1 | 3.00 |
Payoneer Global has a consensus price target of $11.36, suggesting a potential upside of 8.68%. Given Payoneer Global’s stronger consensus rating and higher possible upside, analysts clearly believe Payoneer Global is more favorable than Medical Cannabis Payment Solutions.
Summary
Payoneer Global beats Medical Cannabis Payment Solutions on 12 of the 12 factors compared between the two stocks.
About Medical Cannabis Payment Solutions
Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
About Payoneer Global
Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.
Receive News & Ratings for Medical Cannabis Payment Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Cannabis Payment Solutions and related companies with MarketBeat.com's FREE daily email newsletter.